Top Markets
Coin of the day
NurExone Biologic Inc. NurExone Biologic Inc.

NurExone Biologic Inc.

NRX
Rank in Stocks #27129
NurExone Biologic Inc., a pharmaceutical technology company, develops a... NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.
Share Price
$0.47705898
Last synced: 2026-08-19
Market Cap
$35.01M
Change (1 day)
8.33%
Change (1 year)
-16.23%
Country
CA
Trade NurExone Biologic Inc. (NRX)

Category

Price of NRX with the market cap of B
NurExone Biologic Inc. NurExone Biologic Inc.
NRX
$0.47705898
Market Capitalization of NurExone Biologic Inc.(NRX)
Market Cap: $35.01M
As of August 2026 NurExone Biologic Inc. has a market cap of $35.01M. This makes NurExone Biologic Inc. the world's 27129th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of NurExone Biologic Inc. from 2022 to 2026
NRX compared with Top 5 Most Popular stocks
Price of NRX Asset B Mkt. of B Results
NurExone Biologic Inc. NurExone Biologic Inc.
$72,218.35 $35.01M
$5.301T +15,138,143.76%
NurExone Biologic Inc. NurExone Biologic Inc.
$63,131.23 $35.01M
$4.634T +13,233,322.31%
NurExone Biologic Inc. NurExone Biologic Inc.
$56,443.44 $35.01M
$4.143T +11,831,444.05%
NurExone Biologic Inc. NurExone Biologic Inc.
$48,901.16 $35.01M
$3.589T +10,250,447.63%
NurExone Biologic Inc. NurExone Biologic Inc.
$38,922.70 $35.01M
$2.857T +8,158,787.37%